Arbutus Biopharma Corp (ABUS)
3.21
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
3.22
+0.01
(+0.31%)
Pre-Market: 20:00
Arbutus Biopharma Market Cap: 608.27M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Biomarin Pharmaceutical Inc | 12.52B |
Amicus Therapeutics Inc | 2.928B |
Ionis Pharmaceuticals Inc | 5.627B |
GlycoMimetics Inc | 15.07M |
FibroGen Inc | 40.31M |
Market Cap Related Metrics
PS Ratio | 85.85 |
Price to Book Value | 5.691 |
Price | 3.21 |
Earnings Yield | -13.40% |